New Allscripts (MDRX) CFO Won't Affect M&A Potential - Analyst
Allscripts (Nasdaq: MDRX) stock is lower Monday after announcing Richard J. Poulton will become its new CFO earlier. Some suspect that the new exec will try to stem the possibility of a merger.
One firm taking a different stance is Baird. Amid the new appointment, Baird said the potential for Allscripts to be acquired hasn't changed. In fact, Baird thinks the addition my be a modest positive for Allscipts if the firm decides to remain independent.
Allscripts recently disclosed receiving first-round bids from the likes of Carlyle, Blackstone, and others.
Shares are down 0.3 percent in afternoon trading.
One firm taking a different stance is Baird. Amid the new appointment, Baird said the potential for Allscripts to be acquired hasn't changed. In fact, Baird thinks the addition my be a modest positive for Allscipts if the firm decides to remain independent.
Allscripts recently disclosed receiving first-round bids from the likes of Carlyle, Blackstone, and others.
Shares are down 0.3 percent in afternoon trading.